The Society of MSK Prize

Society of MSK prize
2018 recipient of The Society of Memorial Sloan Kettering Prize, Professor Melvyn Greaves

The Society of Memorial Sloan Kettering Prize is awarded annually to recognize an individual who has made significant or groundbreaking contributions to the field of pediatric oncology. Further, it highlights the longstanding and future facing partnership between The Society and MSK, and affirms the global leadership of MSK in the field of pediatric oncology. 

The 2018 recipient of The Society of Memorial Sloan Kettering Prize is Melvyn Greaves, FRS, Professor of Cell Biology at the Institute of Cancer Research in London. Mel’s teams work on the molecular genetics of childhood leukemia, uncovered the pre-natal origin of this disease, and shed light on its possible infectious causes. Mel’s current research is focused on stem cells, genetic architecture and clonal evolution in leukemia and on the evolutionary biology of cancer. He has eclectic interests in biology, cancer and medicine and is a strong supporter of the public understanding of science. He is the author of the popular science book – 'Cancer. The Evolutionary Legacy' (Oxford University Press). In 2013, he established the Centre for Evolution and Cancer at The Institute of Cancer Research, London. In 2015, Mel was awarded the Cancer Research UK Lifetime Achievement in Cancer Research Prize, and in 2017 the Royal Society’s Royal Medal.

Educating future generations of healthcare professionals is a vital part of MSK’s mission. To highlight this commitment, The Society Prize is awarded at the Annual MSK Academic Convocation to a researcher, physician, or team leader who has made a positive and lasting impact in the fight against pediatric cancer. All biomedical laboratory disciplines are eligible, and there is no geographical limitation to who is eligible for consideration. This prestigious honor provides the recipient with a cash prize, a commemorative award, and the opportunity to lecture at MSK. He or she is selected by MSK’s President and CEO, in consultation with the Physician-In-Chief, and the Director of the Sloan Kettering Institute. 

The Society is thrilled to have Professor Melvyn Greaves as the third recipient of this prize!

2016 Inaugural Society Prize Recipient

The Inaugural Society Prize recipient is Richard J. O’Reilly, MD, Chairman of the MSK Department of Pediatrics and Director of the Bone Marrow Transplantation Program. The much beloved Dr. O’Reilly has been selected based on his transformative research accomplishments over the past 40 years and his extraordinary service to MSK’s pediatric patients and families.

2017 Society Prize Recipient

The 2017 recipient of The Society of Memorial Sloan Kettering Prize is James R. Downing, MD. Dr. Downing, President and CEO of St. Jude’s Children’s Research Hospital in Memphis, Tennessee, is a world-renowned leader in the field of Pediatric cancer research. He has focused his career and research on understand the genetic basis of cancer to improve treatment for children with the disease. Among his many accomplishments, he has had a major influence on defining the genetics and genomics of pediatric cancers. Dr. Downing was instrumental in launching the Pediatric Cancer Genome Project, which has sequenced the normal and cancer genomes of more than 800 young cancer patients with some of the least understood and most aggressive tumors.